⌘K

Login Start Free

Home/Filings/4/0000905148-25-003040

4//SEC Filing

Devroe Eric 4

Accession 0000905148-25-003040

CIK 0001781174other

View on SEC.gov Company Profile

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 5:15 PM ET

Size

16.3 KB

Accession

0000905148-25-003040

Insider Transaction Report

Form 4

Period: 2025-08-14

Acrivon Therapeutics, Inc.ACRV

Chief Operating Officer

Transactions

Tax Payment
Common Stock
2025-08-14$1.39/sh−613$852→ 65,921 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

2 files

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1

filerCIK 0001950573

Filing Metadata

Form type: 4
Filed: Aug 17, 8:00 PM ET
Accepted: Aug 18, 5:15 PM ET
Size: 16.3 KB

View on SEC.gov